retatrutide clinical trials safety trial results The FDA has issued warning letters to multiple companies marketing compounded Retatrutide Retatrutide produces up to I get asked at least

Retatrutide is still a promising product if current trends continue, it may soon become one of the most important tools in modern metabolic medicine

-0.4% for placebo) Weight loss: Average weight loss over 36 weeks: -10.1 kg (15 mg dose group) Significantly superior to subcutaneous semaglutide (-6.2 kg) Gastrointestinal adverse reactions: Nausea (14% vs

Both Wegovy and Zepbound offer powerful tools for managing weight, improving health, and feeling your best

We still need 120,000 to finish 2026

In the end all 3 arms that were originally on retatrutide from the beginning were tightly clustered between 28 and 30% body weight loss